PRESS RELEASE published on 04/04/2023 at 12:00, 3 years 7 months ago Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital
PRESS RELEASE published on 01/05/2023 at 13:00, 3 years 10 months ago Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy
PRESS RELEASE published on 01/03/2023 at 13:00, 3 years 10 months ago Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)
Published on 11/09/2026 at 23:10, 2 hours 37 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 2 hours 47 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 3 hours 15 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 3 hours 32 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 01:20, 26 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 2 hours 52 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 3 hours 36 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 3 hours 42 minutes ago Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
Published on 11/09/2026 at 18:30, 7 hours 17 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 8 hours 12 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
Published on 11/09/2026 at 10:32, 15 hours 15 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 07:00, 18 hours 47 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
